Impact of thymidine phosphorylase and CD163 expression on prognosis in stage II colorectal cancer.

Donia Kaidi Louis Szeponik Ulf Yrlid Yvonne Wettergren Elinor Bexe Lindskog

Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2022)

TYMP expression in tumor epithelial cells was associated with RFS and emphasizes the need for tissue microdissection. Additional studies are needed to establish whether TYMP and CD163 could add clinically relevant information to identify high-risk stage II patients that could benefit from adjuvant chemotherapy.

Keyphrases

poor prognosis
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
binding protein
prognostic factors
healthcare
long non coding rna
health information
patient reported outcomes
social media
patient reported